Clinical trial
Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's…
NCT00045877 · Chiron Corporation, Industry · Completed
Key facts
| NCT number | NCT00045877 |
|---|---|
| Title | Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments |
| Lead sponsor | Chiron Corporation, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin |
| Intervention type | Drug |
| Interventions | Recombinant Human Interleukin-2 and Rituximab |
| First posted | Sep 16, 2002 |
| Last update posted | Feb 6, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: